Ledger.Open graph →
SEC Form D · filed July 11, 2023

MAINZ BIOMED N.V

Offering
$50.0M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MAINZ, 2M
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Gregory Tibbits · Mainz, 2MDirectorChristian Salem · Boston, MAExecRegina Reale · NEW YORK, NYExec · DirectorHeiner Dreismann · Mainz, 2MDirectorGuido Baechler · Mainz, 2MExec · DirectorWilliam Caragol · Mainz, 2MExecDarin Leigh · Mainz, 2MExecSwadesh Mahajan · Austin, TXDirectorRobert C. Dozier · Dallas, TXDirectorChristopher C. Maguire · Dallas, TXDirectorPhillip Freese · Mainz, 2MExecAlberto Libanori · Mainz, 2MDirectorEllen Terchila · Vancouver, Z4ExecMoritz Eidens · Mainz, 2MExec · DirectorWilliam Caragol · Mainz, 2MExecHans Hekland · Mainz, 2MDirectorMike Kotschenreuther · Cedar Park, TXExecNicole Holden · Mainz, 2MDirectorHans Hekland · Mainz, 2MDirectorRomi Mahajan · Bellevue, WAExec · DirectorScott C. Harrington · Dallas, TXDirectorHeiner Dreismann · Mainz, 2MDirectorAlberto Libanori · Mainz, 2MDirectorMoritz Eidens · Mainz, 2MExec · DirectorDarin Leigh · Mainz, 2MExecPhillip Freese · Mainz, 2MExecGuido Baechler · Mainz, 2MExec · DirectorNicole Holden · Mainz, 2MDirectorBrian C. Parro · Dallas, TXDirectorGregory Tibbits · Mainz, 2MDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗